Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
4.050
-0.230 (-5.37%)
Oct 23, 2026, 2:13 PM EDT - Market open
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
43.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Werewolf Therapeutics | 21.00M |
| Apollomics | 8.84M |
| Hyperion DeFi | 1.40M |
| ImageneBio | 800.00K |
| Mereo BioPharma Group | 500.00K |
| iBio, Inc. | 100.00K |
ACET News
- 22 hours ago - Adicet Bio to Participate in Upcoming Investor Conferences - Business Wire
- 22 days ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Adicet Bio price target raised to $28 from $25 at Wedbush - TheFly
- 25 days ago - Adicet Bio trading resumes - TheFly
- 25 days ago - Adicet Bio price target raised to $34 from $27 at H.C. Wainwright - TheFly
- 25 days ago - Adicet Bio trading halted, volatility trading pause - TheFly
- 25 days ago - Adicet Bio Transcript: Study update - Transcripts
- 25 days ago - Adicet Bio Press release: Study update - Filings